HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $135M
Founded date: 2021
Investors 5
| Date | Name | Website |
| 17.09.2021 | Lightspeed... | lsvp.com |
| 08.09.2021 | RA Capital... | racap.com |
| 15.09.2021 | Abingworth... | abingworth... |
| - | Sahsen Ven... | sahsen.com |
| 02.12.2021 | Catalys Pa... | catalyspac... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.09.2021 | - | $135M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 08.09.2021 | HilleVax Closes $135 Million Crossover Financing to Advance ... | HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on the development and commercializat... | marketscre... |
| 08.09.2021 | Takeda's norovirus vaccine spinout, HilleVax, secures $135M ... | HilleVax has garnered a whopping $135 million in investor interest two months after spinning out of ... | fiercebiot... |
| 08.09.2021 | HilleVax Closes $135M Crossover Financing | BOSTON, MA, HilleVax, a biopharmaceutical company, announced the close of a $135 million crossover... | vcnewsdail... |
| 08.09.2021 | HilleVax Closes $135 Million Crossover Financing to Advance ... | Boston, Mass., September 8, 2021 – HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on... | catalyspac... |
| 08.09.2021 | Takeda's norovirus vaccine spinout, HilleVax, secures $135M ... | HilleVax has garnered a whopping $135 million in investor interest two months after spinning out of ... | fiercebiot... |
| 30.07.2021 | Takeda and Frazier Healthcare Partners announce collaboratio... | India: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE: TAK) (Takeda) and Frazier Healthcare Pa... | incubees.c... |
| 29.07.2021 | Takeda Pharmaceutical : and Frazier Healthcare Partners Anno... | Cambridge, Mass. and Menlo Park, Calif., July 29, 2021 - Takeda Pharmaceutical Company Limited (TSE:... | marketscre... |